Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street ↗

January 07, 2023

These companies are reporting financial results that aren't being reflected in their stock market performances.

Via The Motley Fool

Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 21, 2022

From Inari Medical, Inc.

Via GlobeNewswire

What 6 Analyst Ratings Have To Say About Inari Medical ↗

December 20, 2022

Via Benzinga

2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023 ↗

December 02, 2022

These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would suggest.

Via The Motley Fool

Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

November 03, 2022

From Inari Medical, Inc.

Via GlobeNewswire

Analyst Ratings for Inari Medical ↗

November 03, 2022

Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:

Via Benzinga

Where Inari Medical Stands With Analysts ↗

September 29, 2022

Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:

Via Benzinga

Inari Medical Reports Third Quarter 2022 Financial Results

November 02, 2022

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT

October 31, 2022

From Inari Medical, Inc.

Via GlobeNewswire

Where Inari Medical Stands With Analysts ↗

October 17, 2022

Over the past 3 months, 6 analysts have published their opinion on Inari Medical (NASDAQ:NARI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Inari Medical to Announce Third Quarter 2022 Financial Results

October 06, 2022

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus ↗

May 05, 2022

Via Benzinga

Inari Medical: Battling Blood Clots ↗

March 19, 2022

Inari Medical is a small medical outfit whose stock has gone through the wringer for nearly a year — but the story remains terrific and the stock is starting to act better. Let's take a closer look.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Recap: Inari Medical Q4 Earnings ↗

February 23, 2022

Inari Medical (NASDAQ:NARI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022 ↗

September 29, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022 ↗

September 13, 2022

Upgrades See all analyst ratings upgrades.

Via Benzinga

Morgan Stanley Maintains Overweight Rating for Inari Medical: Here's What You Need To Know ↗

July 15, 2022

Morgan Stanley has decided to maintain its Overweight rating of Inari Medical (NASDAQ:NARI) and lower its price target from $108.00 to $93.00. Shares of Inari Medical are trading up 0.74% over the last...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022 ↗

June 21, 2022

Upgrades

Via Benzinga

Inari Medical's Return On Capital Employed Insights ↗

May 23, 2022

Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.

Via Benzinga

A Preview Of Inari Medical's Earnings ↗

May 03, 2022

Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inari...

Via Benzinga

Inari Medical Reports Mixed Q4 Earnings, Guides FY22 Sales Above Consensus ↗

February 24, 2022

Inari Medical Inc's (NASDAQ: NARI) Q4 revenue was $83.2 million, up 14% sequentially and 71% Y/Y, beating the consensus of $78.16 million. The sequential growth was...

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

A Preview Of Inari Medical's Earnings ↗

February 22, 2022

Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

30 Stocks Moving In Tuesday's Mid-Day Session ↗

January 11, 2022

Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year....

Via Benzinga

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗

January 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...

Via Benzinga

21 Stocks Moving in Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...

Via Benzinga

Inari Medical Reports Solid Preliminary Q4, FY21 Sales ↗

January 11, 2022

Inari Medical Inc (NASDAQ: NARI) expects Q4 FY21 sales of $82.8 million - $83.3 million, up 14% sequentially and 71% year-over-year (at the midpoint of the range),...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.